In vitro validation of (R)- and (S)-9-{(1-[18F]flouro-3-hydroxy-2-propoxy)methyl}guanine as radiopharmaceuticals for gene therapy

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 42, Issue SUPPL. 1, 1999, Pages

  Monclus, M ^a   Damhaut, Ph ^a   Luxen, A ^a   Velu, T ^a   Goldman, S ^a  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

Enantiomer; Gene therapy; In vitro; 18F FHPG

Indexed keywords

GUANINE; IN-VITRO; [18F]FHPG;

ACICLOVIR; FLUORINE 18; GANCICLOVIR; GUANINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT; THYMIDINE KINASE;

CANCER THERAPY; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; ENANTIOMER; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; POSITRON EMISSION TOMOGRAPHY; SUICIDE GENE;

HERPES; SIMPLEXVIRUS;

EID: 0032779816     PISSN: 03624803     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (11)